
Massive Acquisition Alert! Johnson & Johnson Expands Neurological Treatment Portfolio
Johnson & Johnson has announced a monumental acquisition that will reshape its footprint in the pharmaceutical industry. The healthcare powerhouse is set to acquire Intra-Cellular Therapies for a staggering $14.6 billion, enhancing its capabilities in treating neurological disorders. This deal involves purchasing